Great Point Partners as of June 30, 2024
Portfolio Holdings for Great Point Partners
Great Point Partners holds 33 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Urogen Pharma (URGN) | 9.3 | $49M | 2.9M | 16.78 | |
| Neurogene (NGNE) | 7.0 | $37M | 1.0M | 36.39 | |
| Abivax Sa Sponsored Ads (ABVX) | 6.3 | $33M | 2.5M | 13.22 | |
| Merus N V (MRUS) | 5.9 | $31M | 523k | 59.17 | |
| Pliant Therapeutics (PLRX) | 5.4 | $28M | 2.6M | 10.75 | |
| Arcellx Common Stock (ACLX) | 5.2 | $27M | 492k | 55.19 | |
| Dynavax Technologies Corp Com New (DVAX) | 5.1 | $27M | 2.4M | 11.23 | |
| Evolus (EOLS) | 5.1 | $27M | 2.5M | 10.85 | |
| Cytokinetics Com New (CYTK) | 4.9 | $26M | 474k | 54.18 | |
| Dianthus Therapeutics (DNTH) | 3.8 | $20M | 758k | 25.88 | |
| Insmed Com Par $.01 (INSM) | 3.2 | $17M | 250k | 67.00 | |
| Zura Bio Class A Ord Shs (ZURA) | 3.1 | $16M | 4.6M | 3.50 | |
| Kalvista Pharmaceuticals (KALV) | 3.0 | $16M | 1.3M | 11.78 | |
| Ionis Pharmaceuticals (IONS) | 3.0 | $16M | 330k | 47.66 | |
| Context Therapeutics (CNTX) | 2.8 | $15M | 7.4M | 2.00 | |
| Amicus Therapeutics (FOLD) | 2.8 | $15M | 1.5M | 9.92 | |
| Optinose | 2.7 | $14M | 14M | 1.04 | |
| Esperion Therapeutics (ESPR) | 2.5 | $13M | 5.8M | 2.22 | |
| Voyager Therapeutics (VYGR) | 2.4 | $13M | 1.6M | 7.91 | |
| Outlook Therapeutics (OTLK) | 2.4 | $13M | 1.7M | 7.38 | |
| Autolus Therapeutics Spon Ads (AUTL) | 2.3 | $12M | 3.4M | 3.48 | |
| Jasper Therapeutics Com New (JSPR) | 1.7 | $9.1M | 402k | 22.70 | |
| Olema Pharmaceuticals (OLMA) | 1.7 | $8.6M | 797k | 10.82 | |
| Terns Pharmaceuticals (TERN) | 1.5 | $7.8M | 1.1M | 6.81 | |
| Miragen Therapeutics (VRDN) | 1.2 | $6.5M | 500k | 13.01 | |
| Tscan Therapeutics (TCRX) | 1.1 | $5.5M | 941k | 5.85 | |
| Vistagen Therapeutics Ord (VTGN) | 1.0 | $5.3M | 1.5M | 3.48 | |
| Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) | 1.0 | $5.1M | 500k | 10.22 | |
| Puma Biotechnology (PBYI) | 0.9 | $4.8M | 1.5M | 3.26 | |
| Kyverna Therapeutics (KYTX) | 0.7 | $3.7M | 499k | 7.50 | |
| Spyre Therapeutics Com New (SYRE) | 0.6 | $3.2M | 135k | 23.51 | |
| Anaptysbio Inc Common (ANAB) | 0.1 | $627k | 25k | 25.06 | |
| Lexicon Pharmaceuticals Com New (LXRX) | 0.0 | $50k | 30k | 1.68 |
